Centene Corp. Hits New 52-Week High at USD 65.80

Centene Corp., a mid-cap player in the healthcare services industry, has reached a significant milestone by hitting a new 52-week high of USD 65.80 on June 8, 2026. This achievement marks a notable recovery from its 52-week low of USD 25.08, reflecting a substantial increase in its stock price over the past year. Despite this recent uptick, Centene's one-year performance stands at -6.89%, contrasting sharply with the S&P 500's impressive gain of 23.42% during the same period. The company's market capitalization is currently valued at USD 16,287 million, and it maintains a price-to-earnings (P/E) ratio of 25.00. Centene's financial metrics indicate a return on equity of 3.30% and a price-to-book ratio of 0.82. Additionally, the company has a debt-to-equity ratio of -0.14, suggesting a unique financial structure. As Centene Corp. continues to navigate the healthcare landscape, this new price point underscores its evolving market position within the industry.